1,4-dihydropyridine has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allessie, MA; Frechen, D; Greiser, M; Haase, H; Hanrath, P; Morano, I; Schotten, U; Stellbrink, C; Vazquez-Jimenez, JF | 1 |
| Lévy, S | 1 |
1 review(s) available for 1,4-dihydropyridine and Chronic Illness
| Article | Year |
|---|---|
Pharmacologic management of atrial fibrillation: current therapeutic strategies.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Chronic Disease; Digoxin; Dihydropyridines; Drug Administration Routes; Electrocardiography; Embolism; Heart Rate; Humans; Practice Guidelines as Topic; Prognosis; Propranolol; Secondary Prevention; Tachycardia, Paroxysmal; Verapamil | 2001 |
1 other study(ies) available for 1,4-dihydropyridine and Chronic Illness
| Article | Year |
|---|---|
The L-type Ca2+-channel subunits alpha1C and beta2 are not downregulated in atrial myocardium of patients with chronic atrial fibrillation.
Topics: Animals; Atrial Fibrillation; Binding Sites; Calcium Channels, L-Type; Chronic Disease; Dihydropyridines; Down-Regulation; Humans; Protein Binding; Rabbits | 2003 |